Drug Pipeline

Nadunolimab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-28 NCT05181462
Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced…		 Trial completed
2026-05-28 NCT05181462
Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced…		 date change Completion moved earlier: 2026-08 -> 2026-05-08
Active Studies by Phase
Phase 2
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07284485 Immunoprevention for High-risk Lung Lesions High-risk Lung Nodules Recruiting
Phase 1/2
NCT07281716 Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC Metastatic Microsatellite Stable Colorectal Carcinoma Recruiting
NCT06548230 A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without… Myelodysplastic Syndrome(MDS) Recruiting
Sponsors Running Nadunolimab Trials
M.D. Anderson Cancer Center (1) Dan Feng (1) Robert Samstein (1)
Disease Areas
Leukemia (1) Acute Myeloid Leukemia (AML) (1) Myelodysplastic Syndromes (MDS) (1)
Get alerts when Nadunolimab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free